Overexpression of SLC2A1, ALDOC, and PFKFB4 in the glycolysis pathway drives strong drug resistance in 3D HeLa tumor cell spheroids
Tong Wang,Xueting Wang,Xuli Zheng,Zhongfang Guo,Ali Mohsin,Yingping Zhuang,Guan Wang
DOI: https://doi.org/10.1002/biot.202400163
2024-09-21
Biotechnology Journal
Abstract:Graphical and Lay Summary 3D HeLa tumor spheroids can better reproduce the characteristics of the tumor microenvironment and are generally more resistant to clinical drugs than 2D monolayer cells. In this study, multi‐omics (transcriptome, proteomics and metabolomics) analysis reveal that the transition from 2D culture to 3D culture is accompanied by hypoxia‐mediated enrichment of extracellular matrix and inhibition of mitochondria‐related pathways and functions. Meanwhile, the glycolysis‐related genes SLC2A1, ALDOC and PFKFB4 are identified as new potential targets to overcome drug resistance in 3D Hela tumor cell spheroids. Our study provides new insights into the treatment of cervical cancer by combining multi‐omics and 3D in vitro models. The 3D multicellular tumor spheroid (MTS) model exhibits enhanced fidelity in replicating the tumor microenvironment and demonstrates exceptional resistance to clinical drugs compared to the 2D monolayer model. In this study, we used multiomics (transcriptome, proteomics, and metabolomics) tools to explore the molecular mechanisms and metabolic differences of the two culture models. Analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment pathways revealed that the differentially expressed genes between the two culture models were mainly enriched in cellular components and biological processes associated with extracellular matrix, extracellular structural organization, and mitochondrial function. An integrated analysis of three omics data revealed 11 possible drug resistance targets. Among these targets, seven genes, AKR1B1, ALDOC, GFPT2, GYS1, LAMB2, PFKFB4, and SLC2A1, exhibited significant upregulation. Conversely, four genes, COA7, DLD, IFNGR1, and QRSL1, were significantly downregulated. Clinical prognostic analysis using the TCGA survival database indicated that high‐expression groups of SLC2A1, ALDOC, and PFKFB4 exhibited a significant negative correlation with patient survival. We further validated their involvement in chemotherapy drug resistance, indicating their potential significance in improving prognosis and chemotherapy outcomes. These results provide valuable insights into potential therapeutic targets that can potentially enhance treatment efficacy and patient outcomes.
biotechnology & applied microbiology,biochemical research methods